DISTRIBUTION OF ABCG2 (BCRP) AND ABCC2 (MRP2) MRNAS IN RAT SMALL INTESTINE AND LIVER

被引:0
作者
Horibe, Sayo [1 ]
Takara, Kohji [1 ]
Minegaki, Tetsuya [1 ]
Ohnishi, Noriaki [1 ,2 ]
Yokoyama, Teruyoshi [1 ,2 ]
机构
[1] Kyoto Pharmaceut Univ, Div Clin Pharmaceut Sci, Dept Clin Pharm, Yamashina Ku, Kyoto 6078414, Japan
[2] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan
来源
EXCLI JOURNAL | 2009年 / 8卷
关键词
Abcg2; Abcc2; ABC transporter; Wistar rat; RT-PCR; expression profile; MULTIDRUG-RESISTANCE PROTEINS; GLUTATHIONE S-TRANSFERASES; ORGANIC ANION TRANSPORTER; ORAL BIOAVAILABILITY; DRUG ABSORPTION; CELL MONOLAYERS; P-GLYCOPROTEIN; EXPRESSION; PHARMACOKINETICS; GLUCURONIDE;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The purpose of this study is to examine the distribution of Abcg2 and Abcc2 mRNAs in the intestine and liver of male Wistar rats, and any regional differences. Nine-week-old male rats were used, and their intestine divided equally into nine segments. The expression patterns of Abcg2 and Abcc2 mRNAs in the intestine and liver were examined using a reverse transcription-polymerase chain reaction (RT-PCR). PCR products for Abcg2 mRNA were readily detectable in the intestine, but no bands were detected in the liver. In addition, the level of Abcg2 mRNA increased significantly from the duodenum to ileum, indicating a regional difference in Abcg2 mRNA expression in the intestine. This regional difference was comparable to that of Abcb1/mdr1a as reported previously. On the other hand, Abcc2 mRNA was detected at a higher level in the liver than in the intestine. However, there was no regional difference in Abcc2 mRNA expression in the intestine. Collectively, Abcg2 was predominant in the intestine rather than liver in male Wistar rats, whereas Abcc2 was predominant in the liver. These findings will provide useful information for evaluating the gastrointestinal secretion of drugs as well as drug-drug interactions in rats.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 25 条
[1]   Role of breast cancer resistance protein (Bcrp1/Abcg2) in the extrusion of glucuronide and sulfate conjugates from enterocytes to intestinal lumen [J].
Adachi, Y ;
Suzuki, H ;
Schinkel, AH ;
Sugiyama, Y .
MOLECULAR PHARMACOLOGY, 2005, 67 (03) :923-928
[2]   Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model [J].
Cao, Xianhua ;
Gibbs, Seth T. ;
Fang, Lanyan ;
Miller, Heather A. ;
Landowski, Christopher P. ;
Shin, Ho-Chul ;
Lennernas, Hans ;
Zhong, Yanqiang ;
Amidon, Gordon L. ;
Yu, Lawrence X. ;
Sun, Duxin .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1675-1686
[3]   Comparison of oral absorption and bioavailability of drugs between monkey and human [J].
Chiou, WL ;
Buehler, PW .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :868-874
[4]   Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3 [J].
Chu, XY ;
Huskey, SEW ;
Braun, MP ;
Sarkadi, B ;
Evans, DC ;
Evers, R .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 309 (01) :156-164
[5]  
CLIFTON G, 1977, CANCER RES, V37, P788
[6]  
Dean M, 2001, J LIPID RES, V42, P1007
[7]   ABC of oral bioavailability: transporters as gatekeepers in the gut [J].
Dietrich, CG ;
Geier, A ;
Elferink, RPJO .
GUT, 2003, 52 (12) :1788-1795
[8]   Allometric pharmacokinetic scaling: Towards the prediction of human oral pharmacokinetics [J].
Feng, MR ;
Lou, XC ;
Brown, RR ;
Hutchaleelaha, A .
PHARMACEUTICAL RESEARCH, 2000, 17 (04) :410-418
[9]  
Gotoh Y, 2000, J PHARMACOL EXP THER, V292, P433
[10]   The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin [J].
Greiner, B ;
Eichelbaum, M ;
Fritz, P ;
Kreichgauer, HP ;
Von Richter, O ;
Zundler, J ;
Kroemer, HK .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :147-153